
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Direct reprogramming of human fibroblasts into dopaminergic neuron-like cells
Xinjian Liu, Li Fang, Elizabeth A. Stubblefield, et al.
Cell Research (2011) Vol. 22, Iss. 2, pp. 321-332
Open Access | Times Cited: 183
Xinjian Liu, Li Fang, Elizabeth A. Stubblefield, et al.
Cell Research (2011) Vol. 22, Iss. 2, pp. 321-332
Open Access | Times Cited: 183
Showing 1-25 of 183 citing articles:
In Vivo Direct Reprogramming of Reactive Glial Cells into Functional Neurons after Brain Injury and in an Alzheimer’s Disease Model
Ziyuan Guo, Lei Zhang, Zheng Wu, et al.
Cell stem cell (2013) Vol. 14, Iss. 2, pp. 188-202
Open Access | Times Cited: 756
Ziyuan Guo, Lei Zhang, Zheng Wu, et al.
Cell stem cell (2013) Vol. 14, Iss. 2, pp. 188-202
Open Access | Times Cited: 756
Direct Lineage Reprogramming: Strategies, Mechanisms, and Applications
Jun Xu, Yuanyuan Du, Hongkui Deng
Cell stem cell (2015) Vol. 16, Iss. 2, pp. 119-134
Open Access | Times Cited: 392
Jun Xu, Yuanyuan Du, Hongkui Deng
Cell stem cell (2015) Vol. 16, Iss. 2, pp. 119-134
Open Access | Times Cited: 392
Small molecules enable neurogenin 2 to efficiently convert human fibroblasts into cholinergic neurons
Meng-Lu Liu, Tong Zang, Yuhua Zou, et al.
Nature Communications (2013) Vol. 4, Iss. 1
Open Access | Times Cited: 322
Meng-Lu Liu, Tong Zang, Yuhua Zou, et al.
Nature Communications (2013) Vol. 4, Iss. 1
Open Access | Times Cited: 322
Induction of functional dopamine neurons from human astrocytes in vitro and mouse astrocytes in a Parkinson's disease model
Pia Rivetti di Val Cervo, Roman A. Romanov, Giada Spigolon, et al.
Nature Biotechnology (2017) Vol. 35, Iss. 5, pp. 444-452
Closed Access | Times Cited: 315
Pia Rivetti di Val Cervo, Roman A. Romanov, Giada Spigolon, et al.
Nature Biotechnology (2017) Vol. 35, Iss. 5, pp. 444-452
Closed Access | Times Cited: 315
How to make a midbrain dopaminergic neuron
Ernest Arenas, Mark Denham, J. Carlos Villaescusa
Development (2015) Vol. 142, Iss. 11, pp. 1918-1936
Open Access | Times Cited: 291
Ernest Arenas, Mark Denham, J. Carlos Villaescusa
Development (2015) Vol. 142, Iss. 11, pp. 1918-1936
Open Access | Times Cited: 291
Alzheimer’s disease, dementia, and stem cell therapy
Thomas Duncan, Michael Valenzuela
Stem Cell Research & Therapy (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 285
Thomas Duncan, Michael Valenzuela
Stem Cell Research & Therapy (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 285
Evaluating cell reprogramming, differentiation and conversion technologies in neuroscience
Jérôme Mertens, Maria C. Marchetto, Cédric Bardy, et al.
Nature reviews. Neuroscience (2016) Vol. 17, Iss. 7, pp. 424-437
Open Access | Times Cited: 282
Jérôme Mertens, Maria C. Marchetto, Cédric Bardy, et al.
Nature reviews. Neuroscience (2016) Vol. 17, Iss. 7, pp. 424-437
Open Access | Times Cited: 282
Recent advances on drug development and emerging therapeutic agents for Alzheimer’s disease
Teeba Athar, Khalid Al Balushi, Shah Alam Khan
Molecular Biology Reports (2021) Vol. 48, Iss. 7, pp. 5629-5645
Open Access | Times Cited: 181
Teeba Athar, Khalid Al Balushi, Shah Alam Khan
Molecular Biology Reports (2021) Vol. 48, Iss. 7, pp. 5629-5645
Open Access | Times Cited: 181
Reprogramming Fibroblasts into Bipotential Hepatic Stem Cells by Defined Factors
Bing Yu, Zhiying He, Pu You, et al.
Cell stem cell (2013) Vol. 13, Iss. 3, pp. 328-340
Open Access | Times Cited: 163
Bing Yu, Zhiying He, Pu You, et al.
Cell stem cell (2013) Vol. 13, Iss. 3, pp. 328-340
Open Access | Times Cited: 163
Neural stem cell‐based treatment for neurodegenerative diseases
Seung Up Kim, Hong J. Lee, Yun B. Kim
Neuropathology (2013) Vol. 33, Iss. 5, pp. 491-504
Open Access | Times Cited: 159
Seung Up Kim, Hong J. Lee, Yun B. Kim
Neuropathology (2013) Vol. 33, Iss. 5, pp. 491-504
Open Access | Times Cited: 159
Generation of functional human serotonergic neurons from fibroblasts
Krishna C. Vadodaria, Jérôme Mertens, Apuã C.M. Paquola, et al.
Molecular Psychiatry (2015) Vol. 21, Iss. 1, pp. 49-61
Open Access | Times Cited: 123
Krishna C. Vadodaria, Jérôme Mertens, Apuã C.M. Paquola, et al.
Molecular Psychiatry (2015) Vol. 21, Iss. 1, pp. 49-61
Open Access | Times Cited: 123
The occurrence of intracranial rhabdoid tumours in mice depends on temporal control of Smarcb1 inactivation
Zhi‐Yan Han, Wilfrid Richer, Paul Fréneaux, et al.
Nature Communications (2016) Vol. 7, Iss. 1
Open Access | Times Cited: 102
Zhi‐Yan Han, Wilfrid Richer, Paul Fréneaux, et al.
Nature Communications (2016) Vol. 7, Iss. 1
Open Access | Times Cited: 102
Stem Cell Therapy for Alzheimer’s Disease: A Review of Recent Clinical Trials
Jae Myeong Kang, Byeong Kil Yeon, Seong‐Jin Cho, et al.
Journal of Alzheimer s Disease (2016) Vol. 54, Iss. 3, pp. 879-889
Closed Access | Times Cited: 95
Jae Myeong Kang, Byeong Kil Yeon, Seong‐Jin Cho, et al.
Journal of Alzheimer s Disease (2016) Vol. 54, Iss. 3, pp. 879-889
Closed Access | Times Cited: 95
Making neurons, made easy: The use of Neurogenin-2 in neuronal differentiation
Amy E. Hulme, Simon Maksour, Mitchell St Clair‐Glover, et al.
Stem Cell Reports (2021) Vol. 17, Iss. 1, pp. 14-34
Open Access | Times Cited: 83
Amy E. Hulme, Simon Maksour, Mitchell St Clair‐Glover, et al.
Stem Cell Reports (2021) Vol. 17, Iss. 1, pp. 14-34
Open Access | Times Cited: 83
The use of fibroblasts as a valuable strategy for studying mitochondrial impairment in neurological disorders
Margrethe A. Olesen, Francisca Villavicencio-Tejo, Rodrigo A. Quintanilla
Translational Neurodegeneration (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 38
Margrethe A. Olesen, Francisca Villavicencio-Tejo, Rodrigo A. Quintanilla
Translational Neurodegeneration (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 38
Models of Herpes Simplex Virus Latency
Paige N. Canova, Audra J. Charron, David A. Leib
Viruses (2024) Vol. 16, Iss. 5, pp. 747-747
Open Access | Times Cited: 8
Paige N. Canova, Audra J. Charron, David A. Leib
Viruses (2024) Vol. 16, Iss. 5, pp. 747-747
Open Access | Times Cited: 8
Advances in Stem Cell Therapy for Huntington’s Disease: A Comprehensive Literature Review
Siddharth Shah, Hadeel M. Mansour, Brandon Lucke–Wold
Cells (2025) Vol. 14, Iss. 1, pp. 42-42
Open Access | Times Cited: 1
Siddharth Shah, Hadeel M. Mansour, Brandon Lucke–Wold
Cells (2025) Vol. 14, Iss. 1, pp. 42-42
Open Access | Times Cited: 1
Somatic cell reprogramming for Parkinson's disease treatment
X Li, Kevin Fang, F. Wang
Ibrain (2025) Vol. 11, Iss. 1, pp. 59-73
Open Access | Times Cited: 1
X Li, Kevin Fang, F. Wang
Ibrain (2025) Vol. 11, Iss. 1, pp. 59-73
Open Access | Times Cited: 1
Mesenchymal stem cells and neuroregeneration in Parkinson's disease
Aleksandra Glavaski‐Joksimovic, Martha C. Bohn
Experimental Neurology (2013) Vol. 247, pp. 25-38
Closed Access | Times Cited: 100
Aleksandra Glavaski‐Joksimovic, Martha C. Bohn
Experimental Neurology (2013) Vol. 247, pp. 25-38
Closed Access | Times Cited: 100
Development-Inspired Reprogramming of the Mammalian Central Nervous System
Ryoji Amamoto, Paola Arlotta
Science (2014) Vol. 343, Iss. 6170
Open Access | Times Cited: 92
Ryoji Amamoto, Paola Arlotta
Science (2014) Vol. 343, Iss. 6170
Open Access | Times Cited: 92
The effect of substrate topography on direct reprogramming of fibroblasts to induced neurons
Karina Kulangara, Andrew F. Adler, Hong Wang, et al.
Biomaterials (2014) Vol. 35, Iss. 20, pp. 5327-5336
Open Access | Times Cited: 91
Karina Kulangara, Andrew F. Adler, Hong Wang, et al.
Biomaterials (2014) Vol. 35, Iss. 20, pp. 5327-5336
Open Access | Times Cited: 91
Clinical Trials in a Dish: The Potential of Pluripotent Stem Cells to Develop Therapies for Neurodegenerative Diseases
Kelly Haston, Steven Finkbeiner
The Annual Review of Pharmacology and Toxicology (2015) Vol. 56, Iss. 1, pp. 489-510
Open Access | Times Cited: 81
Kelly Haston, Steven Finkbeiner
The Annual Review of Pharmacology and Toxicology (2015) Vol. 56, Iss. 1, pp. 489-510
Open Access | Times Cited: 81
Nanogrooved substrate promotes direct lineage reprogramming of fibroblasts to functional induced dopaminergic neurons
Junsang Yoo, Myungkyung Noh, Hong Nam Kim, et al.
Biomaterials (2015) Vol. 45, pp. 36-45
Closed Access | Times Cited: 77
Junsang Yoo, Myungkyung Noh, Hong Nam Kim, et al.
Biomaterials (2015) Vol. 45, pp. 36-45
Closed Access | Times Cited: 77
Proneural bHLH Genes in Development and Disease
Carol Huang, Jennifer A. Chan, Carol Schuurmans
Current topics in developmental biology/Current Topics in Developmental Biology (2014), pp. 75-127
Closed Access | Times Cited: 76
Carol Huang, Jennifer A. Chan, Carol Schuurmans
Current topics in developmental biology/Current Topics in Developmental Biology (2014), pp. 75-127
Closed Access | Times Cited: 76
Mesenchymal Stem Cell Therapy and Alzheimer’s Disease: Current Status and Future Perspectives
Ji‐Eun Kim, Yujeong Lee, Seulah Lee, et al.
Journal of Alzheimer s Disease (2020) Vol. 77, Iss. 1, pp. 1-14
Closed Access | Times Cited: 62
Ji‐Eun Kim, Yujeong Lee, Seulah Lee, et al.
Journal of Alzheimer s Disease (2020) Vol. 77, Iss. 1, pp. 1-14
Closed Access | Times Cited: 62